HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregor Sersa Selected Research

Bleomycin (Blenoxane)

1/2022Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells.
1/2022Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity.
10/2021Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status.
8/2021Bleomycin Concentration in Patients' Plasma and Tumors after Electrochemotherapy. A Study from InspECT Group.
8/2021PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice.
1/2021Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: A matched cohort analysis from the InspECT registry.
1/2020Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer.
10/2019Radiological findings of porcine liver after electrochemotherapy with bleomycin.
3/2019Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.
1/2019Electrochemotherapy of superficial tumors - Current status:: Basic principles, operating procedures, shared indications, and emerging applications.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregor Sersa Research Topics

Disease

94Neoplasms (Cancer)
02/2022 - 01/2002
41Melanoma (Melanoma, Malignant)
12/2021 - 04/2002
14Neoplasm Metastasis (Metastasis)
08/2021 - 06/2007
11Sarcoma (Soft Tissue Sarcoma)
09/2017 - 04/2002
10Carcinoma (Carcinomatosis)
10/2021 - 04/2002
8Fibrosarcoma
12/2014 - 02/2003
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 04/2014
6Breast Neoplasms (Breast Cancer)
10/2021 - 07/2004
6Necrosis
03/2020 - 07/2004
4Adenocarcinoma
01/2015 - 12/2009
3Skin Neoplasms (Skin Cancer)
01/2021 - 01/2018
3Hypoxia (Hypoxemia)
03/2020 - 09/2005
3Hepatocellular Carcinoma (Hepatoma)
01/2018 - 03/2010
3Hemorrhage
08/2012 - 05/2009
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2018
2Experimental Melanoma
12/2015 - 01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Triple Negative Breast Neoplasms
08/2021
1Bites and Stings (Sting)
03/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
01/2021
1Papillomavirus Infections
01/2020
1Pain (Aches)
12/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Body Weight (Weight, Body)
09/2017
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
09/2017
1Wounds and Injuries (Trauma)
04/2017
1Fibrosis (Cirrhosis)
01/2016

Drug/Important Bio-Agent (IBA)

32Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 05/2004
28Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2002
27Interleukin-12 (IL 12)IBA
02/2022 - 11/2009
27DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2002
10Pharmaceutical PreparationsIBA
01/2022 - 01/2002
9CytokinesIBA
02/2022 - 12/2007
8Small Interfering RNA (siRNA)IBA
03/2020 - 01/2013
8PlatinumIBA
01/2020 - 07/2002
7EndoglinIBA
03/2017 - 01/2013
6Green Fluorescent ProteinsIBA
11/2013 - 04/2002
5Radiation-Sensitizing AgentsIBA
01/2021 - 01/2003
4CD146 AntigenIBA
12/2021 - 10/2014
4Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2012
4Oxygen (Dioxygen)IBA
05/2010 - 01/2002
3Biological ProductsIBA
10/2021 - 03/2011
3Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2021 - 02/2018
3Immune Checkpoint InhibitorsIBA
08/2021 - 01/2019
3Messenger RNA (mRNA)IBA
05/2018 - 01/2013
3Peptides (Polypeptides)IBA
05/2015 - 09/2013
3LuciferasesIBA
12/2014 - 01/2006
3Vinblastine (Vinblastine Sulfate)FDA Link
07/2014 - 07/2002
2olaparibIBA
10/2021 - 08/2021
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2021 - 08/2021
2AntigensIBA
03/2020 - 03/2017
2OvalbuminIBA
01/2019 - 04/2017
2CollagenIBA
01/2017 - 01/2012
2Therapeutic UsesIBA
12/2015 - 11/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
05/2015 - 01/2013
2IntegrinsIBA
11/2013 - 04/2002
21-aminomethylphosphonic acidIBA
11/2013 - 09/2013
2Nucleic AcidsIBA
01/2013 - 06/2012
2Hydralazine (Apresoline)FDA LinkGeneric
01/2003 - 01/2002
1Sunitinib (Sutent)FDA Link
01/2022
1pembrolizumabIBA
08/2021
1Neoplasm Antigens (Tumor Antigens)IBA
08/2021
1CholesterolIBA
01/2021
1Simvastatin (Zocor)FDA LinkGeneric
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2021
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021
1Cancer VaccinesIBA
03/2020
1VaccinesIBA
03/2020
12-diethylaminoethanol (DEAE)IBA
01/2020
1AnionsIBA
01/2020
1Blood Proteins (Serum Proteins)IBA
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1diethylamineIBA
01/2020
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
03/2019
1DNA VaccinesIBA
01/2019
1Melanoma-Specific AntigensIBA
01/2019
1Granzymes (Granzyme)IBA
10/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1Keratins (Keratin)IBA
09/2017
1Platinum Compounds (Compounds, Platinum)IBA
09/2017
1AntibodiesIBA
04/2017
1CathelicidinsIBA
04/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1VemurafenibIBA
09/2016
1Interferon-alpha (Interferon Alfa)IBA
03/2016
1CyclodextrinsIBA
06/2015
1Concanavalin AIBA
06/2015
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
06/2015

Therapy/Procedure

47Therapeutics
01/2022 - 05/2004
11Radiotherapy
12/2021 - 05/2004
11Electrodes (Electrode)
12/2019 - 05/2009
7Drug Therapy (Chemotherapy)
01/2020 - 05/2004
4Immunotherapy
02/2022 - 01/2017
4Aftercare (After-Treatment)
01/2020 - 09/2006
2Radiofrequency Ablation
01/2021 - 09/2014
2Lasers (Laser)
01/2018 - 01/2002
1Retreatment
12/2019
1Intravenous Injections
01/2016